baber/WOPTO huggingface dataset:
Patent NZ-231415-A (NZ)
Title: Conveying apparatus for rotating and closing lidded cartons: restraint members act as a fulcrum to rotate the carton
Inventor: HEMUS DAVID STANLEY
IPC: B65G47/244
Filed: 1989-11-16
Abstract: An apparatus for closing lidded cartons (9) has a turning station (36) including a flightless horizontal conveyor, and a chain conveyor (80) which extends along one side of the flightless conveyor (44) and has light restraint members (86) pivotally mounted on its links (84). The chain conveyor (80) is moved in the same direction as the horizontal conveyor, but at a slower speed. Part way along the chain conveyor an upwardly directed air jet (100) moves the restraint members (86) individually but in succession to temporary raised positions in which they are available for engagement by a carton (9A) which is moving along the flightless conveyor in overlapping relation to the chain conveyor. A restraint member engaged by a carton in this way thereafter serves as a fulcrum about which the carton pivots through a substantial angle. Plough bars later complete the rotation of the carton through 90 DEG  in total.
Patent NZ-232890-A (NZ)
Title: Reduction of cholesterol content of fat by formation of cholesterol-cyclodextrin complexes
Inventor: RODERBOURG HURBERT
IPC: C11B11/00
Filed: 1990-03-13
Abstract: Process consisting in bringing the fatty matter into contact with a cyclodextrin, with stirring and in the presence of water, the water/fatty matter weight ratio, temperature and stirring being controlled so that a fine emulsion of the oil-in-water type is formed, and in then separating the cyclodextrin-cholesterol and cyclodextrin-free fatty acids complexes thus formed. <IMAGE>
Patent NZ-233015-A (NZ)
Title: Acryloyl-substituted pyrrole derivatives (distamycin a analogues) and pharmaceutical compositions
Inventor: MONGELLI NICOLA
IPC: A61P35/00
Filed: 1990-03-21
Abstract: The invention relates to acryloyl substituted pyrrole derivatives of formula (I) <CHEM>  wherein n is an integer of 1 to 5; each of R1 and R2, which may be the same or different, is hydrogen, halogen, -CN, -NO2, C1-C4 alkyl, or a group <CHEM>  R3 is hydrogen, halogen, -CN, or -NO2;  each R4 is, independently, hydrogen or C1-C4 alkyl;  A is a bond, a group <CHEM>  or a group -NH-Het-CO-, wherein Het is a saturated or unsaturated pentatomic or hexatomic heteromonocyclic ring;  and  B is a group <CHEM> in which m is 1, 2 or 3 and each R5 is, independently, a C1-C4 alkyl group, and pharmaceutically acceptable salts thereof, which are useful as antineoplastic agents.
Patent NZ-234931-A (NZ)
Title: Sulphonyl urea derivatives, preparation and pharmaceutical compositions thereof
Inventor: MOHRS KLAUS
IPC: A61K31/64
Filed: 1990-08-16
Abstract: Substituted N-(quinolin-2-ylmethoxy)benzylsulphonylureas are prepared by reaction of (quinolin-2-ylmethoxy)benzylamines with sulphonyl isocyanates. The substituted N-(quinolin-2-ylmethoxy)benzylsulphonylureas can be employed as active substances in medicaments, in particular as lipoxygenase inhibitors.
Patent NZ-240690-A (NZ)
Title: Flashback plug for catheter; plug has integral porous filter material which allows passage of air but not blood, and groove for venting air through plug when a fitting is placed therein
Inventor: PETERSON GERALD HEBER
IPC: A61M25/06
Filed: 1991-11-21
Abstract: A flashback plug (10) has a body molded of a semi-translucent polymeric material along and about an axis. A distal end (13) of the body (12) engages in fluid tight communication a needle hub flash chamber (14) and a proximal end (15) extends therefrom to receive a fitting (21). A passage (16) extends through the body along the axis from the proximal end to the distal end (13) to permit flow therethrough. A vent membrane (18) of a hydrophobic filter media is mounted by its periphery across the passage. The vent membrane (18) is insert molded within the body to capture the proximally extending periphery thereof so that liquid in the passage distal end (13) can not reach the proximal end (15). The proximal end (15) of the passage (16) has the shape of a female luer taper which terminates distally with at the vent membrane (18). A pair of opposed channels (25) extend longitudinally and parallel to the axis from the vent membranes (18) to the proximal end (15). The distal end (13) of the body (12) has an outside a male luer for engaging the needle hub flash chamber (14). <IMAGE>
Patent NZ-243159-A (NZ)
Title: Inhibitory polypeptide or bacteriocin to gram positive bacteria from lactococcus lactis subspecies lactis and its production
Inventor: VEDAMUTHU EBENEZER R
IPC: A61P31/04
Filed: 1992-06-16
Abstract: A bacteriocin or polypeptide (LL-2 SEQ ID NO:2) derived from Lactococcus lactis subspecies lactis NRRL-B-18809 is described. Sequenced DNA and polypeptide precursor encoded thereby (SEQ ID NO: 1) are described. Methods of use and production of the polypeptide LL-2 are described.
Patent NZ-249937-A (NZ)
Title: A pharmaceutical composition for wound healing including a non-fibrotic growth factor
Inventor: FERGUSON MARK WILLIAM JAMES
IPC: A61P17/02
Filed: 1993-03-22
Abstract: A healing composition containing at least one non-fibrotic growth factor in combination with a pharmaceutically acceptable carrier is disclosed. A method of preparation of the composition and method of treating a host, suffering from a wound or fibrotic condition, disease, disorder with the composition is also disclosed.
Patent NZ-253782-A (NZ)
Title: Medication administering device - medication forced from a first chamber by gas generated in a second expandsible chamber
Inventor: GROSS JOSEPH
IPC: A61K9/22
Filed: 1993-07-09
Abstract: A medication administering device includes a housing introducible into a body cavity and of a material insoluble in the body cavity fluids, but formed with an opening covered by a material which is soluble in body cavity fluids. A diaphragm divides the interior of the housing into a medication chamber including the opening, and a control chamber. An electrolytic cell in the control chamber generates a gas when electrical current is passed therethrough to deliver medication from the medication chamber through the opening into the body cavity at a rate controlled by the electrical current.
Patent NZ-272001-A (NZ)
Title: Substituted 5-(phenyl)-pyrimidine derivatives and medicaments
Inventor: LEACH MICHAEL JOHN
IPC: C07D239/48
Filed: 1991-05-31
Abstract: The invention provides a series of compounds of formula (I) <CHEM>  and salts thereof, wherein for example, R<1> and R<2>, which may be the same or different each represent -NR<1><3>R<1><4> where R<1><3> and R<1><4> may each independently represent hydrogen or alkyl or, taken together with the nitrogen atom to which they are attached form a heterocyclic ring, optionally substituted by one or more alkyl or arylalkyl groups and optionally containing a further heteroatom;  R<3> is hydrogen, haloalkyl, alkoxymethyl or alkyl;  R<4> is hydrogen, nitro or halo;  R<5> is hydrogen or halo;  R<6> is hydrogen, halo, nitro, amino, alkylamino or dialkylamino;  R<7> is hydrogen or halo;  R<8> is hydrogen or halo; The compounds may be used for the treatment or prophylaxis of a neurodegenerative or other neurological disorder of the CNS, the aetiology or which includes excessive release of the neurotransmitter glutamate.
Patent NZ-291988-A (NZ)
Title: 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepine and medicaments thereof
Inventor: CLAREMON DAVID A
IPC: C07D243/24
Filed: 1995-08-17
Abstract: This invention is concerned with novel compounds represented by structural formula I    <IMAGE>  I  where X and Y are independently hydrogen, chloro, fluoro, bromo, iodo, or trifluoromethyl and n is 0, 1 or 2; R is hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl, methyl, or methoxy; and the racemates, mixtures of enantiomers, individual diastereomers or individual enantiomers with all isomeric forms and pharmaceutically acceptable salts, hydrates or crystal forms thereof, which are antiarrhythmic agents.
Patent NZ-299460-A (NZ)
Title: 13-substituted milbemycin 5-oxime derivatives; veterinary pesticides
Inventor: KAZUO SATO
IPC: A61P31/14
Filed: 1996-09-27
Abstract: Compounds of formula (I): <CHEM> in which: R<1> is methyl, ethyl, isopropyl or sec-butyl; X is carbonyl or methylene; Z is =C=(R<2>)2 or =C=(CH2)m (in which R<2> is alkyl, and m is integer of from 2 to 5); n is 0 or 1; R<3> is nitro, amino, alkylamino, dialkylamino, alkoxy, alkoxyalkoxy, or a group (iii), (iv), (v), (vi), (vii), (viii) or (ix): <CHEM>   <CHEM>   <CHEM>   <CHEM> (in which: R<4> represents: alkyl; substituted alkyl; cycloalkyl having from 3 to 6 carbon atoms; substituted cycloalkyl; alkenyl; alkynyl; carbocyclic aryl; or heterocyclic; R<5> is hydrogen atom or alkyl; R<6> represents: hydrogen; alkyl; or cycloalkyl; R<7> represents: alkyl; cycloalkyl; carbocyclic aryl; or aralkyl; or R<6> and R<7>, together with the nitrogen atom to which they are attached, are fused to form heterocyclic ring; Y is oxygen or sulphur; r is 1, 2 or 3; Q is methylene or carbonyl; R<8> is: alkyl or carbocyclic aryl; R<9> is: alkyl; cycloalkyl; carbocyclic aryl ; or aralkyl; R<10> is heterocyclic; and R<11> is alkyl); have valuable acaricidal, insecticidal and anthelmintic activities.
Patent NZ-301752-A (NZ)
Title: Sliding bogie trailer with wheeled bogie section slideable connected to chassis by way of fifth wheel clasp
Inventor: RAVEN KEVIN WILLIAM
IPC: B62D53/06
Filed: 1996-02-16
Abstract: The present invention relates to sliding bogie trailers, and in particular to an extendible flatbed trailer which may loaded and unloaded by a crane. The trailer 201 comprises a chassis section and a wheeled bogie section 203 slidably connected to the chassis section and relatively movable between extended and retracted positions at which positions the sections may be secured into engagement with each other. The sections have load bearing floors, the floor of one section sliding under the floor 205 of the other section 203 when the sections are moved to a retracted position. Either the trailer 201 or a truck tractor unit 291 has a crane 292 mounted on or nearest the section having the floor which slides under the other floor 205. Preferably, the crane 292 has an arm with a reach sufficient to load the section farthest from the crane only when the sections are in the retracted position. <IMAGE>
Patent NZ-328205-A (NZ)
Title: Sump comprising an elongate valve operable externally of the sump
Inventor: WALKER JOHN SIDNEY
IPC: E03F5/14
Filed: 1997-09-27
Abstract: A sump comprises a wall or walls (pipe 1), a floor 3, an entry (from race 2) to the sump, a debris outlet 4 in the floor, a water outlet 5 formed in the wall or walls and spaced above the floor, and elongate valve means 8 extending above the debris outlet, operable externally of the sump and adapted to open or close the debris outlet.  The valve means 8 may be a tubular member guided within at least one sleeve 17 which is spaced from the side or sides of the sump by support arms 15.
Patent NZ-331452-A (NZ)
Title: use of 2-(4-indolyl-1-piperazinyl)alkylene-N-(2-pyridyl)-cyclohexane- carboxamide derivatives in treating central nervous system disorders
Inventor: BRIGHTWELL CHRISTOPHER IAN
IPC: A61P25/18
Filed: 1995-06-01
Abstract: iperazine derivatives as 5-HT1A-antagonists are disclosed which have general formula A, where Ra and Rb are each hydrogen or methyl and Rc is hydrogen, halo or C1-4 alkyl optionally in the form of a pharmaceutically acceptable acid addition salt. The compounds are useful in the treatment of CNS disorders.
Patent NZ-336125-A (NZ)
Title: Process for hydrating a gelling agent
Inventor: FIERRO LOUIS ANTHONY
IPC: A61Q19/10
Filed: 1997-12-10
Abstract: Process for compatibly hydrating a fragmented solid which forms a gel with an aqueous composition where: a) generating an aqueous composition and a oily composition comprising the fragmented solid; b) combining them together in the absence of air; c) contacting the combined composition with a means for vibratorily mixing the combined composition so as to hydrate the said fragmented solid to the extent that it is compatibilized into the composition and provides a stable gelled aqueous composition.
Patent NZ-500963-A (NZ)
Title: Regulation of quinolate phosphoribosyl transferase (QPRTase) expression
Inventor: CONKLING MARK A
IPC: C12N15/11
Filed: 1998-06-10
Abstract: DNA encoding a plant quinolate phosphoribosyl transferase (QPRTase) enzyme, constructs comprising such DNA and methods of altering quinolate phosphoribosyl transferase expression are provided. Nicotine is produced in tobacco plants by the condensation of nicotinic acid and 4-methylaminobutanal.  The biosynthetic pathway resulting in nicotine production is illustrated in FIG 1.  Two regulatory loci (Nicl and Nic2) act as co-dominant regulators of nicotine production . Enzyme analyses of roots of single and double Nic mutants show that the activities of QPRTase and PMTase are directly proportional to levels of nicotine biosynthesis.  A comparison of enzyme activity in tobacco tissues (root and callus) with different capacities for nicotine synthesis shows that QPRTase activity is strictly correlated with nicotine content. Tobacco plants with reduced QPRTase expression and reduced nicotine levels are desirable in the production of tobacco products having reduced nicotine content.  The constructs herein may also be useful in providing transgenic plants having increased QPRTase expression and increased nicotine content in the plant.  Such constructs, methods using these constructs and the plants so produced may be desirable in the production of tobacco products having altered nicotine content, or in the production of plants having nicotine content increased for its insecticidal effects. It has been shown that the TobRD2 gene encodes a Nicotiana tabacum QPRTase, and provided herein is the cDNA sequence of NtQPTl (formerly termed TobRD2) and the amino acid sequence of the encoded enzyme. Comparisons of the NtQPTl amino acid sequence with the GenBank database reveal limited sequence similarity to bacterial proteins that encode QPRTase.
Patent NZ-507046-A (NZ)
Title: Rope traction elevator having a horizontal output drive shaft attached to a traction sheave
Inventor: LATORRE MARCUZ CARLOS
IPC: B66B11/00
Filed: 1999-06-23
Abstract: The specification describes a rope traction elevator in which the motor axis is arranged axially with the input drive shaft and parallel to the plane of the traction sheave. It is characterized in that  in the horizontal plane the gear casing on at least  the side of the input drive shaft does not extend beyond the vertical projection of the motor casing.  This is best illustrated by Fig. 5 which shows a cross-section of the gear case 28 on the plane cutting the gear case 28 marked in Fig. 2. Fig. 5 shows an ideal contour for the case wall in relation to strength and torsional rigidity for this gear 2. The height h of the external case contour is greater than the width b. In the example shown, the contour of the gear case, which was calculated using the method of finite elements, has four different radii R1-R4 along its perimeter, although the number of radii which flow into each other can be greater or less than four. This results in the wall of the gear case having a cross-section with a shape similar to an oval. The case wall can also be kept relatively thin, which also has a positive effect on the external dimensions and the weight of the gear 2.
Patent NZ-509171-A (NZ)
Title: Method for indentifying segragating index phenotype modifying single point mutations
Inventor: DOVE WILLIAM F
IPC: C12Q1/6827
Filed: 1999-07-12
Abstract: A method for identifying a segregating, index phenotype- modifying single point mutation in a non-human animal, wherein the single point mutation occurs at a modifier locus and the index phenotype is conferred by an index locus, comprises the steps of: Outcrossing at least one male animal of a non-human founder inbred strain, the male animal carrying random point mutations relative to a would type animal of the founder inbred strain, to at least one female animal of a non-human index inbred strain. The female animal carrying a congenic dominant allele at the index locus, displaying the index phenotype and being genetically distinguishable from the founder inbred strain. To produce F1 progeny, a portion of which carry both of the dominant allele at the index locus and at least one random point mutation; Identifying one or more F1 individuals displaying an outlaying phenotype relative to the index phenotype displayed by the female animal of the index inbred strain, thereby indicating that at least one F1 individual possesses an index phenotype-modifying mutation; Backcrossing gametes from male F1 progeny to at least one female of the index inbred strain with or without the index allele to produce N2 backcross progeny, wherein at least one of the N2 backcross progeny that carry the dominant allele also exhibit the outlaying phenotype and verifying that the outlaying phenotype is caused by a segregating single point mutation. Preferably the animals are a mice.
Patent NZ-510578-A (NZ)
Title: Energy management system and method
Inventor: WOOLARD JOHN W
IPC: G06F3/0481
Filed: 1999-09-23
Abstract: An energy management system (12) and method is provided for energy users with large physical plants (14) which provides these energy users with a comprehensive understanding of the energy consumption of their physical plant (14) and with the ability to manage it in a way that makes sense for their business. The system (12) may include three-dimensional facilities navigation tools, powerful energy consumption analysis processes, TCP/IP communication capabilities and a World Wide Web (WWW)-based interface. The system (12) also includes a real-time data retrieval and dissemination process, which permits real-time energy data to be communicated within the system (12).
Patent NZ-513375-A (NZ)
Title: Refrigerant gauge manifold with built-in charging calculator having pressure and temperature sensors for measuring the level of coolant
Inventor: GONG YING
IPC: F25B45/00
Filed: 2001-08-06
Abstract: A gauge manifold (30) is connectable to the suction (20a) and liquid lines (20b) of an air conditioning refrigerant circuit (10) and has a built-in charge level calculator (48) into which system manufacturing and capacity data is enterable and stored. The charging data input and stored within the calculator is automatically utilised in conjunction with ambient temperature and refrigeration pressure levels sensed by the calculator to generate a visual display, indicating whether the circuit's refrigerant charge level is acceptable, high or low for the system being checked. The gauge manifold is connected to a pressurised refrigerant canister (72) or recycling drum (74) and a valve portion (40, 42) of the manifold is manually operated to add or remove refrigerant according to the calculator display.
Patent NZ-513694-A (NZ)
Title: Testing vapour recovery systems
Inventor: CARTER RODNEY
IPC: B67D7/04
Filed: 2000-02-21
Abstract: A method of testing a volatile liquid tank farm together with a vapour recovery system, to collect vapour from the tanks at the time of re-filling them with volatile liquid.  The tank farm has individual fill-pipes (13) for each tank (10) with each fill-pipe outlet below the normal minimum liquid level in the tank and each tank having a vent-pipe (11) connected to a common manifold (25). To perform the test, the common manifold is closed to atmosphere and one side of a shut-off valve (17) is connected to the manifold (25), a flow meter (20) being connected to the other side of the shut-off valve. Flow meters (22, 23) are coupled to all but one of the fill-pipes (13), the shut-off valve (17) is opened to allow liquid to be supplied to the remaining fill-pipe so as to increase the volume of liquid in the associated tank, and the out-flow of gas or wet vapour from the common manifold (25) is monitored for substantial correlation to the volume of liquid admitted to the tank associated with the remaining fill-pipe.
Patent NZ-515936-A (NZ)
Title: Antigenic Neisserial peptides
Inventor: MASIGNANI VEGA
IPC: A61K48/00
Filed: 2000-05-19
Abstract: Proteins comprising antigenic fragment from Neisseria meningitides and Neisseria gonorrhoeae; nucleic acids encoding the proteins; a composition comprising the proteins; and the use of the proteins in the preparation of a medicament for the treatment of a Neisserial infection.
Patent NZ-519691-A (NZ)
Title: Process for the preparation of pyrazolo[1,5-B]pyridazine derivatives
Inventor: MATHEWS NEIL
IPC: A61P29/00
Filed: 2000-12-20
Abstract: A process for the preparation of a compound formula (I), which comprises oxidizing under conventional conditions the corresponding formula (II), in regards to formula(I) where, R0 is a halogen, C1-6alkyl, C1-6alkoxy, C1-6alkoxy substituted by one or more fluorine atoms, or O(CH2)nNR4R5; R1 and R2 are independently selected from H, C1-6alkyl, C1-6alkyl substituted by one or fluorine atoms, C1-6alkyoxy, C1-6 hydroxyalkyl, SC1-6alkyl, C(O)H, C(O) C1-6alkyl, C1-6alkylsulphonyl, C1-6alkoxy substituted by one or fluorine atoms, O(CH2)nCO2C1-6alkyl, O(CH2)nSC1-6alkyl, (CH2)nNR4R5, (CH2)nSC1-6alkyl or C(O)NR4R5, (CH2)nSC1-6alkyl or C(O)NR4R5; R3 is C1-6alkyl or NH2; R4 and R5 are independently selected from H, or C1-6alkyl or together with the nitrogen atom to which they are attached, form a 4-8 membered saturated ring; and n is 1-4; where R0 and R3 are as defined for formula (I) below.
Patent NZ-524145-A (NZ)
Title: Anti-IL-12 mammalian, chimeric, humanized or CDR-grafted antibodies for use in treating IL-12 related conditions such as psoriasis and multiple sclerosis
Inventor: GILES-KOMAR JILL
IPC: A61P/
Filed: 2001-08-07
Abstract: Described are anti-IL-12 antibodies, including isolated nucleic acids that encode at least one anti-IL-12 antibody, IL-12 vectors, host cells, transgenic animals or plants, and methods of making and use thereof, including therapeutic compositions, methods and devices.
Patent NZ-527966-A (NZ)
Title: Non-oriented packaging films containing coextruded polyester and nylon layers
Inventor: SCHELL THOMAS ANDREW
IPC: B32B27/34
Filed: 2003-09-02
Abstract: A multilayered thermoformable structure for packaging film applications such as packaging food and medical articles to protect them against external contamination and abuse is disclosed, wherein the multilayered structure comprises: (a) a first film layer of polyester; (b) a second layer of an adhesive; (c) a third layer comprising a nylon or nylon blend; and the first layer, the second layer and the third layer are formed into a flexible film by coextrusion process such as a slot cast or a single-bubble blown coextrusion process, wherein the film is non-oriented. The multilayered structure forming the flexible film may also contain less than 500 ppm of a transition metal salt such as manganese II, manganese III, iron II, iron III, cobalt II, cobalt III, nickel II, nickel III, copper II, copper III, rhodium II, rhodium III, rhodium IV and ruthenium.
Patent NZ-531435-A (NZ)
Title: Radio transmission system and method and transmission station apparatus and reception station apparatus used in the radio transmission system
Inventor: SAWAHASHI MAMORU
IPC: H04J13/10
Filed: 2002-08-30
Abstract: A radio transmission system configured to, on the occasion of radio transmission of information between a transmitter and a receiver, perform the radio transmission of information using an orthogonal frequency and code division multiplexing transmission scheme of parallelly transmitting identical information by a plurality of sub-carriers, wherein the transmitter comprises: converting means for parallelly converting channel-coded information according to symbols transmitted simultaneously; and spreading means for spreading a sequence of parallelized symbols in at least one of a frequency direction and a time direction by a spreading code sequence of a spreading factor determined based on a plurality of changeable spreading factors.